Tumor-related osteomalacia followed after treatment by hyperparathyroidism

Citation
A. Heylen et al., Tumor-related osteomalacia followed after treatment by hyperparathyroidism, REV RHUM, 66(1), 1999, pp. 53-57
Citations number
24
Categorie Soggetti
Rheumatology
Journal title
REVUE DU RHUMATISME
ISSN journal
11698446 → ACNP
Volume
66
Issue
1
Year of publication
1999
Pages
53 - 57
Database
ISI
SICI code
1169-8446(199901)66:1<53:TOFATB>2.0.ZU;2-L
Abstract
Tumor-induced osteomalacia is due to renal phosphate wasting in response to a humoral factor produced by a tumor, usually a benign mesenchymal tumor. Removal of the tumor is followed by resolution of the metabolic disorder. P hysicians should be aware that sporadic renal phosphate wasting in an adult should prompt a search for a tumor. A case of tumor-induced osteomalacia d ue to a nonossifying fibroma of the radius is reported. After removal of th e tumor, renal phosphate excretion returned to normal, but the patient deve loped tertiary hyperparathyroidism. Eight years elapsed between symptom ons et and the diagnosis of the tumor. The pathogenesis of tumor-induced osteom alacia and the role of treatment for renal phosphate wasting on the subsequ ent development of hyperthyroidism are discussed.